AzTrials
AzTrials

Hip FracturesNCT04748354

Reducing Fall Risk Post Hip Fracture in Mild Cognitive Impairment

A study testing Otago Exercise Program in people with Hip Fractures and Mild Cognitive Impairment, run by University of British Columbia at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Hip fracture is recognized as one of the most serious consequences of osteoporosis, less than half regain pre-fracture independence. 95% of all hip fractures in older adults are due to falls. Thus, reducing fall risk while restoring function post-hip fracture is critical. Read more about this study

Who is it for?
Ages 65 years and older
Conditions the study is for
Hip Fractures, Mild Cognitive Impairment
What is being tested?
Otago Exercise Program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteCanada
Study dates
3 May 2021to 9 May 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Inclusion Criteria: 1) aged 65 or older; 2) sustained a fall-related hip fracture in the last 12 months and have returned home; 3) have preserved general cognition as indicated by a Mini-Mental State Examination (MMSE) score = or > 20/30; 4) have subjective memory complaints, determined by interview;22 5) score < 26/30 on the Montreal Cognitive Assessment (MoCA); 6) have an absence of significant functional impairment and no dementia as determined by a physician; 7) are not expected to start, or are stable (i.e., > 3 months) on a fixed dose of anti-dementia medications (e.g., donepezil, galantamine) during the RCT; 8) are expected to live > 12 months (based on the geriatricians' expert opinion); 9) can read, write, and speak English with acceptable visual and auditory acuity; 10) are able to walk 3 meters with or without an assistive device; and 1) provide written informed consent.

Exclusion Criteria: 1) diagnosed with or suspected to have (by the geriatrician) a neurodegenerative disease (e.g., Parkinson's disease) or dementia; 2) had a clinical stroke; or 3) have a history indicative of carotid sinus sensitivity (i.e., syncopal falls).

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • University of British Columbia

    Vancouver, British Columbia

Other trials in Canada

About this study

Official title: Reshaping the Path Post Hip Fracture in Mild Cognitive Impairment

Hip fracture is recognized as one of the most serious consequences of osteoporosis, less than half regain pre-fracture independence. 95% of all hip fractures in older adults are due to falls. Thus, reducing fall risk while restoring function post-hip fracture is critical. Many with fall-related hip fractures have cognitive impairment; cognitive impairment increases the risk of falls. The purpose of this 6-month proof-of-concept randomized controlled trial (RCT) is to assess the efficacy of the home-based Otago Exercise Program (OEP) compared with usual care in reducing fall risk among older adults with mild cognitive impairment (MCI) and a fall-related hip fracture.

Read the detailed description

Hip fracture is recognized as one of the most serious consequences of osteoporosis, less than half regain pre-fracture independence. 95% of all hip fractures in older adults are due to falls. Thus, reducing fall risk while restoring function post-hip fracture is critical. Many with fall-related hip fractures have cognitive impairment and they are less likely to regain pre-fracture level of function than those without cognitive impairment. Cognitive impairment also increase falls risk. It is currently unknown whether exercise is efficacious in reducing fall risk and promoting function among older adults with mild cognitive impairment (MCI) and a fall-related hip fracture. The purpose of this 6-month proof-of-concept RCT is to assess the efficacy of the home-based Otago Exercise Program (OEP) compared with usual care in reducing fall risk among community-dwelling older adults with MCI and a fall-related hip fracture.

Being tested
Otago Exercise Program, Usual Care
Keywords
Mobility, Exercise, Fall Risk
Medical subject headings
Hip Fractures, Cognitive Dysfunction, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Otago Exercise ProgramBehavioural

    Also called Exercise

    An individualized and home-based program of progressive strength and balance training exercises delivered by a physical therapist

  • Usual CareOther

    Clinical care provided by a geriatrician.

Study groups in NCT04748354
Study groupRoleWhat they receive
Usual CareActive comparatorClinical care provided by geriatricians. Each participant will see the geriatrician at baseline and 6 months.
Receives: Other: Usual Care
Usual Care with ExerciseExperimentalClinical care provided by geriatricians. Each participant will see the geriatrician at baseline and 6 months. In addition, they will receive the Otago Exercise Program, an individualized and home-based program of progressive strength and balance training exercises delivered by a physical therapist.
Receives: Behavioral: Otago Exercise Program; Other: Usual Care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Physiological Profile Assessment

    A measure of fall risk (z-score).

    Measured: Baseline to 6 Months

Secondary outcomes (18)
  1. Change in Short Physical Performance Battery

    A measure of balance and mobility (out of 12 points).

    Measured: Baseline to 3 Months and 6 Months

  2. Change in Usual Gait Speed

    Gait speed over 4 meters (m/s).

    Measured: Baseline to 3 Months and 6 Months

  3. Change in Life Space Assessment

    Mobility within a life-space level.

    Measured: Baseline to 3 Months and 6 Months

  4. Change in NIH Cognitive Toolbox

    Cognitive performance of executive functions.

    Measured: Baseline to 3 Months and 6 Months

  5. Change in Digit Symbol Substitute Test

    Cognitive performance of processing speed.

    Measured: Baseline to 3 Months and 6 Months

  6. Change in Center for Epidemiological Studies Depression Scale

    Mood

    Measured: Baseline to 3 Months and 6 Months

  7. Change in Positive and Negative Affect Scale

    Mood

    Measured: Baseline to 3 Months and 6 Months

  8. Change in EQ-5D-5L

    Quality of Life

    Measured: Baseline to 3 Months and 6 Months

  9. Change in ICE-CAP

    Wellbeing

    Measured: Baseline to 3 Months and 6 Months

  10. Change in Physical Activity for the Elderly

    Physical activity over the last 7 days

    Measured: Monthly from Baseline to 6 Months

  11. Total Number of Prospective Falls

    Self-report of falls using calendars

    Measured: Monthly from Baseline to 6 Months

  12. Change in Activities Specific Balance Confidence

    Fall-related self efficacy

    Measured: Baseline to 3 Months and 6 Months

  13. Change in Physiological Profile Assessment

    A measure of fall risk (z-score); higher z scores indicate higher risk of falls.

    Measured: Baseline to 3 Months

  14. Change in Timed Up and Go Test

    A measure of functional mobility; greater time for completion indicate poorer performance.

    Measured: Baseline to 3 Months and 6 Months

  15. Change in Fried Frailty

    A measure of physical frailty

    Measured: Baseline to 3 Months and 6 Months

  16. Change in Clinical Frailty Scale

    A measure of frailty; higher value indicate more frailty

    Measured: Baseline to 3 Months and 6 Months

  17. Change in Pittsburgh Sleep Quality Index

    A measure of subjective sleep quality

    Measured: Baseline to 3 Month and 6 Months

  18. Change in Rey Auditory Verbal Learning

    A measure of episodic memory; higher scores indicate bettter episodic performance.

    Measured: Baseline to 3 Month and 6 Months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Feb 2021
  2. Study start3 May 2021
  3. Primary completion30 Mar 2024
  4. Study completion9 May 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Usual care vs. Usual Care with Exercise
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04748354
Sponsor's protocol ID
H19-03812
Status last verified
Nov 2025
First submitted
1 Feb 2021
Last updated
24 Nov 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Otago Exercise Program in people with Hip Fractures and Mild Cognitive Impairment, run by University of British Columbia at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Physiological Profile Assessment (time frame: Baseline to 6 Months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Nov 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in